Grant: Doctoral: Vanier Canada Graduate Scholarships
McMaster University
$150,000.00
The Shared Neurobiology of Autism and Fragile X Syndrome through the Neuroligin Gene Family
EF 2010-11
Résumé
Autism spectrum disorders (ASDs) are characterized by impairments in social interaction, communication, and repetitive behaviour. The impact of ASDs on individuals and their families is life-changing. Diagnosis has risen considerably in the last 20 years, yet very little is known about this complex disorder. The annual costs related to caring for a patient is up to five times the amount for an individual without the disease. The lifetime public expenditure per patient is in the millions of dollars. Fragile X syndrome is the most common inherited mental disorder. Studies report that 25% of males and 6% of females with Fragile X have a form of ASD. Understanding the reasons behind the overlap between these two disorders will be key to improving our understanding of both conditions and greatly enhance the development of treatment.
This study will examine brain development in mouse models of these two disorders. The two models are the valproic-acid (VPA) model of autism and the Fragile X knockout. When pregnant mothers (both human and mouse) are exposed to VPA, their offspring's behaviour mimics the symptoms of autism. In the latter model, the mice lack the same protein that is lacking in human cases of Fragile X. In these mice, I will examine molecules that regulate signalling between brain cells that are risk genes for ASDs. Disruptions in these molecules change the connectivity between cells, resulting in impairments in behaviour. Using techniques to determine when brain circuitry matures, I will compare these mouse brains during the first month of development, which correlates to the period of infancy and childhood in humans.
This study will address how connectivity in the brain occurs, which is a component implicated in developmental brain disorders. Understanding this is paramount in our knowledge of what causes these two disorders and for developing new therapeutic targets, allowing improvements to the current treatment regimes for these diseases.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
217898
Name
Lai Jonathan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The Shared Neurobiology of Autism and Fragile X Syndrome through the Neuroligin Gene Family
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Behavioural Neuroscience; Immunohistochemistry; Molecular Neurobiology; Neurodevelopment Disease; Patch Clamp Physiology
Abstract
Autism spectrum disorders (ASDs) are characterized by impairments in social interaction, communication, and repetitive behaviour. The impact of ASDs on individuals and their families is life-changing. Diagnosis has risen considerably in the last 20 years, yet very little is known about this complex disorder. The annual costs related to caring for a patient is up to five times the amount for an individual without the disease. The lifetime public expenditure per patient is in the millions of dollars. Fragile X syndrome is the most common inherited mental disorder. Studies report that 25% of males and 6% of females with Fragile X have a form of ASD. Understanding the reasons behind the overlap between these two disorders will be key to improving our understanding of both conditions and greatly enhance the development of treatment.
This study will examine brain development in mouse models of these two disorders. The two models are the valproic-acid (VPA) model of autism and the Fragile X knockout. When pregnant mothers (both human and mouse) are exposed to VPA, their offspring's behaviour mimics the symptoms of autism. In the latter model, the mice lack the same protein that is lacking in human cases of Fragile X. In these mice, I will examine molecules that regulate signalling between brain cells that are risk genes for ASDs. Disruptions in these molecules change the connectivity between cells, resulting in impairments in behaviour. Using techniques to determine when brain circuitry matures, I will compare these mouse brains during the first month of development, which correlates to the period of infancy and childhood in humans.
This study will address how connectivity in the brain occurs, which is a component implicated in developmental brain disorders. Understanding this is paramount in our knowledge of what causes these two disorders and for developing new therapeutic targets, allowing improvements to the current treatment regimes for these diseases.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lai, Jonathan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~